New stent aims to keep heart arteries open longer
NCT ID NCT03471845
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a special stent coated with a drug called zotarolimus to treat people with blocked heart arteries. The stent is placed during a procedure to open the artery and slowly releases medication to prevent re-blockage. About 591 participants in China are being followed to see how safe and effective the stent is over time.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Zotarolimus-eluting coronary stent system
- What this could lead to
- If successful, this stent could offer a safe and effective way to treat blocked heart arteries, reducing the need for repeat procedures.
- What could go wrong
- This is a single-arm study without a comparison group, so results may be less conclusive. Stents carry risks like blood clots or re-narrowing of the artery.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ARTERIOSCLEROSIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Affiliated Hospital of Jiangsu University
Zhenjiang, Jiangsu, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Software-Guided heart procedures: a new standard for coronary care?
- Can better healthcare access save hearts after prison?
- Heart patients may stay active longer with coach calls and group support
- Sitting less could be a lifeline for frail hearts – a new trial tests a simple program
- Can balloon timing make or break heart artery success?
- Can lifestyle choices after a stroke extend life and prevent a second one?